Literature DB >> 16410408

A novel mechanism of action of methyl-2-cyano-3,12 dioxoolean-1,9 diene-28-oate: direct permeabilization of the inner mitochondrial membrane to inhibit electron transport and induce apoptosis.

Ismael Samudio1, Marina Konopleva, Helene Pelicano, Peng Huang, Olga Frolova, William Bornmann, Yunming Ying, Randall Evans, Rooha Contractor, Michael Andreeff.   

Abstract

Methyl-2-cyano-3,12 dioxoolean-1,9 diene-28-oate (CDDO-Me) is a synthetic oleanolic acid derivative that displays antitumorigenic and anti-inflammatory activities, and we have previously reported that this agent potently activates the intrinsic apoptotic pathway in leukemia cells. In this study, we demonstrate that mitochondrial dysfunction induced by CDDO-Me is mediated by direct permeabilization of the inner mitochondrial membrane, which results in the rapid depletion of mitochondrial glutathione (GSXm), loss of cardiolipin, and inhibition of mitochondrial respiration. More importantly, we demonstrate that in addition to activating the intrinsic apoptotic pathway, the mitochondrial effects of CDDO-Me may mediate its anti-inflammatory activity by modulating the generation of superoxide anion (O2*). It is noteworthy that CDDO-Me did not increase the generation of O2* and pretreatment of leukemia cells with CDDO-Me prevented the increase of this reactive oxygen species elicited by inhibition of complex I or III in the absence of de novo protein synthesis. CDDO-Me, but not other inhibitors of respiration, induced a time- and dose-dependent, cyclosporin A-independent permeability transition (PT) of isolated mitochondria that was sensitive to sulfhydryl antioxidants but not to EDTA. PT induced by CDDO-Me and Ca2+ was accompanied by loss of GSXm, suggesting that the increased permeability of the inner mitochondrial membrane facilitates the loss of this antioxidant. Finally, transmission electron microscopy revealed that CDDO-Me rapidly induced caspase-independent mitochondrial swelling and loss of inner membrane structure before the release of cytochrome c. Taken together, our results indicate that CDDO-Me is a novel mitochondriotoxic agent that induces apoptosis and inhibits mitochondrial electron transport via perturbations in inner mitochondrial membrane integrity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410408     DOI: 10.1124/mol.105.018051

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  32 in total

1.  Role of peroxisome proliferator-activated receptor-gamma and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia.

Authors:  Twee Tsao; Steven Kornblau; Stephen Safe; Julie C Watt; Vivian Ruvolo; Wenjing Chen; Yihua Qiu; Kevin R Coombes; Zhenlin Ju; Maen Abdelrahim; Wendy Schober; Xiaoyang Ling; Dimitris Kardassis; Colin Meyer; Aaron Schimmer; Hagop Kantarjian; Michael Andreeff; Marina Konopleva
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha.

Authors:  Steffen Koschmieder; Francesco D'Alò; Hanna Radomska; Christine Schöneich; Ji Suk Chang; Marina Konopleva; Susumu Kobayashi; Elena Levantini; Nanjoo Suh; Annalisa Di Ruscio; Maria Teresa Voso; Julie C Watt; Ramasamy Santhanam; Bülent Sargin; Hagop Kantarjian; Michael Andreeff; Michael B Sporn; Danilo Perrotti; Wolfgang E Berdel; Carsten Müller-Tidow; Hubert Serve; Daniel G Tenen
Journal:  Blood       Date:  2007-08-01       Impact factor: 22.113

3.  Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.

Authors:  Indira Jutooru; Gayathri Chadalapaka; Maen Abdelrahim; Md Riyaz Basha; Ismael Samudio; Marina Konopleva; Michael Andreeff; Stephen Safe
Journal:  Mol Pharmacol       Date:  2010-05-20       Impact factor: 4.436

4.  Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia Cells.

Authors:  Un-Ho Jin; Yating Cheng; Beiyan Zhou; Stephen Safe
Journal:  Mol Pharmacol       Date:  2017-03-08       Impact factor: 4.436

5.  Combining the FLT3 inhibitor PKC412 and the triterpenoid CDDO-Me synergistically induces apoptosis in acute myeloid leukemia with the internal tandem duplication mutation.

Authors:  Rehan Ahmad; Suiyang Liu; Ellen Weisberg; Erik Nelson; Ilene Galinsky; Colin Meyer; Donald Kufe; Surender Kharbanda; Richard Stone
Journal:  Mol Cancer Res       Date:  2010-06-22       Impact factor: 5.852

6.  Synthetic triterpenoid cyano enone of methyl boswellate activates intrinsic, extrinsic, and endoplasmic reticulum stress cell death pathways in tumor cell lines.

Authors:  Palaniyandi Ravanan; Renata Sano; Priti Talwar; Satoshi Ogasawara; Shu-ichi Matsuzawa; Michael Cuddy; Sanjay K Singh; G S R Subba Rao; Paturu Kondaiah; John C Reed
Journal:  Mol Cancer Ther       Date:  2011-07-11       Impact factor: 6.261

7.  Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax).

Authors:  Marina Konopleva; Julie Watt; Rooha Contractor; Twee Tsao; David Harris; Zeev Estrov; William Bornmann; Hagop Kantarjian; Jean Viallet; Ismael Samudio; Michael Andreeff
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

8.  Human neuroblastoma cells rapidly enter cell cycle arrest and apoptosis following exposure to C-28 derivatives of the synthetic triterpenoid CDDO.

Authors:  Jennifer L Alabran; Adam Cheuk; Karen Liby; Michael Sporn; Javed Khan; John Letterio; Konstantin S Leskov
Journal:  Cancer Biol Ther       Date:  2008-05-07       Impact factor: 4.742

9.  Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.

Authors:  Melinda S Yates; Quynh T Tran; Patrick M Dolan; William O Osburn; Soona Shin; Colin C McCulloch; Jay B Silkworth; Keiko Taguchi; Masayuki Yamamoto; Charlotte R Williams; Karen T Liby; Michael B Sporn; Thomas R Sutter; Thomas W Kensler
Journal:  Carcinogenesis       Date:  2009-04-21       Impact factor: 4.944

Review 10.  Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.

Authors:  Karen T Liby; Michael B Sporn
Journal:  Pharmacol Rev       Date:  2012-09-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.